Medicines Manufacturing Data Institute: Phase 1
Ref: GRT-CB7YDNRY
Funding Available
Up to £500,000
UK Wide
Life Sciences & Health
14 October 2026
Grants & Funding
About This Grant
UK registered organisations can apply for a share of up to £500,000 for a phase 1 project to establish the Medicines Manufacturing Data Institute (MMDI).
What Can It Fund?
- Establish the Medicines Manufacturing Data Institute (MMDI)
Funding Source
Innovate UK
Explore More
Similar Grants
Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats. Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats.
Invite only: Precision prevention: biological mechanisms of response variation
Apply for funding to investigate why biomedical prevention interventions work differently across people. Projects must generate mechanistic evidence in humans by testing biomedical experimental interventions or challenges in pre-disease or early disease states, providing insight into how to improve the targeting and effectiveness of precision prevention strategies.
Water4All 2026 call: sustainable water management
Funding for UK-based researchers to collaborate with international partners and submit joint applications for sustainable water management research.